Development Generally. Commencing upon the Effective Date and subject to Section 4 and other terms of this Agreement, as between Durect and Alpharma, Alpharma shall be responsible, at its sole Cost, for development of and procuring Regulatory Approval for the Product in the Territory (all such activities the “Development Program”).
Appears in 2 contracts
Sources: Development and License Agreement (Alpharma Inc), Development and License Agreement (Durect Corp)